Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 1
Submit an article Journal homepage
2,320
Views
8
CrossRef citations to date
0
Altmetric
Research Paper

The interaction of TEA domain transcription factor 4 (TEAD4) and Yes-associated protein 1 (YAP1) promoted the malignant process mediated by serum/glucocorticoid regulated kinase 1 (SGK1)

Songlin Hea Department of Cardiothoracic Surgery, The Second People’s Hospital of Chengdu, Chengdu, Sichuan, ChinaView further author information
,
Hanlu Zhangb Department of Thoracic Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan, ChinaView further author information
,
Zongwei Xiaoa Department of Cardiothoracic Surgery, The Second People’s Hospital of Chengdu, Chengdu, Sichuan, ChinaView further author information
,
Sandeep Bhushana Department of Cardiothoracic Surgery, The Second People’s Hospital of Chengdu, Chengdu, Sichuan, ChinaView further author information
,
Ke Gaoa Department of Cardiothoracic Surgery, The Second People’s Hospital of Chengdu, Chengdu, Sichuan, ChinaView further author information
&
Wenping Wangb Department of Thoracic Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan, ChinaCorrespondence[email protected]
View further author information
Pages 601-614 | Received 03 Dec 2020, Accepted 22 Jan 2021, Published online: 10 Feb 2021

References

  • Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma [J]. Lancet. 2013;381(9864):400–412.
  • Domper Arnal MJ, Ferrández Arenas Á, Lanas Arbeloa Á. Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries [J]. World J Gastroenterol. 2015;21(26):7933–7943.
  • Zhang S, Zhou D. Role of the transcriptional coactivators YAP/TAZ in liver cancer [J]. Curr Opin Cell Biol. 2019;61::64–71.
  • Giraud J, Molina-Castro S, Seeneevassen L, et al. Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells [J]. Int J Cancer. 2020;146(8):2255–2267.
  • Tang JY, Yu CY, Bao YJ, et al. TEAD4 promotes colorectal tumorigenesis via transcriptionally targeting YAP1 [J]. Cell Cycle. 2018;17(1):102–109.
  • Liu Y, Wang G, Yang Y, et al. Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner [J]. Oncogene. 2016;35(21):2789–2800.
  • Li Y, Liu S, Ng EY, et al. Structural and ligand-binding analysis of the YAP-binding domain of transcription factor TEAD4 [J]. Biochem J. 2018;475(12):2043–2055.
  • Mesrouze Y, Meyerhofer M, Bokhovchuk F, et al. Effect of the acylation of TEAD4 on its interaction with co-activators YAP and TAZ [J]. Protein Sci. 2017;26(12):2399–2409.
  • Yoo G, Kim T, Chung C, et al. The novel YAP target gene, SGK1, upregulates TAZ activity by blocking GSK3β-mediated TAZ destabilization [J]. Biochem Biophys Res Commun. 2017;490(3):650–656.
  • Conza D, Mirra P, Calì G, et al. The SGK1 inhibitor SI113 induces autophagy, apoptosis, and endoplasmic reticulum stress in endometrial cancer cells [J]. J Cell Physiol. 2017;232(12):3735–3743.
  • Ueki S, Fujishima F, Kumagai T, et al. NDRG1 in esophageal squamous cell carcinoma: their correlation with therapeutic outcome of neoadjuvant chemotherapy [J]. BMC Cancer. 2020;20(1):161.
  • Zhao B, Ye X, Yu J, et al. TEAD mediates YAP-dependent gene induction and growth control [J]. Genes Dev. 2008;22(14):1962–1971.
  • Jordan T, Mastnak DM, Palamar N, et al. Nutritional therapy for patients with esophageal cancer [J]. Nutr Cancer. 2018;70(1):23–29.
  • Kato H, Nakajima M. Treatments for esophageal cancer: a review [J]. Gen Thorac Cardiovasc Surg. 2013;61(6):330–335.
  • Short MW, Burgers KG, Fry VT, et al. [J]. Am Fam Physician. 2017;95(1):22–28.
  • Sakamoto T, Fujiogi M, Matsui H, et al. Comparing perioperative mortality and morbidity of minimally invasive esophagectomy versus open esophagectomy for esophageal cancer: a nationwide retrospective analysis [J]. Ann Surg. 2019. DOI:10.1097/SLA.0000000000003500
  • Chen MF, Yang YH, Lai CH, et al. Outcome of patients with esophageal cancer: a nationwide analysis [J]. Ann Surg Oncol. 2013;20(9):3023–3030.
  • Wang X, Li G, Luo Q, et al. Identification of crucial genes associated with esophageal squamous cell carcinoma by gene expression profile analysis [J]. Oncol Lett. 2018;15(6):8983–8990.
  • He S, Gao K, Mao L, et al. Gene silencing of transcription factor TEAD4 inhibits esophageal cancer cells by regulating TCF7 [J]. Cancer Biother Radiopharm. 2020;10. doi:10.1089/cbr.2020.3870.
  • Zhang W, Li J, Wu Y, et al. TEAD4 overexpression promotes epithelial-mesenchymal transition and associates with aggressiveness and adverse prognosis in head neck squamous cell carcinoma [J]. Cancer Cell Int. 2018;18:178.
  • Shuai Y, Ma Z, Liu W, et al. TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2 [J]. Mol Cancer. 2020;19(1):6.
  • Wu Y, Zheng Q, Li Y, et al. Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells [J]. J Exp Clin Cancer Res. 2019;38(1):376.
  • Liu W, Wang X, Liu Z, et al. SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-Foxo3a pathway [J]. Br J Cancer. 2017;117(8):1139–1153.
  • Amato R, D’Antona L, Porciatti G, et al. Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation [J]. J Mol Med (Berl). 2009;87(12):1221–1239.
  • Bai JA, Xu GF, Yan LJ, et al. SGK1 inhibits cellular apoptosis and promotes proliferation via the MEK/ERK/p53 pathway in colitis [J]. World J Gastroenterol. 2015;21(20):6180–6193.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.